PhytochemistryPharmacology & ToxicologyPeer-reviewed journal article
Anti-Toxoplasma gondii screening of eight species and bio-guided identification of metabolites of Elaeis guineensis leaves, a preliminary study
Nangouban OuattaraiD, Mansour Issoufou TiniiD, Abdulmagid Alabdul MagidiD, Sandie Escotte‐BinetiD, Philomène Akoua Yao-Kouassi, Isabelle VillenaiD, Laurence Voutquenne‐NazabadiokoiD
Abstract
The apicomplexan parasite Toxoplasma gondii causes toxoplasmosis, a ubiquitous and cosmopolitan parasitosis, generally asymptomatic and potentially dangerous for the fetus and highly immunocompromised patients. Pyrimethamine and sulfadiazine, supplemented with folic acid, are the drugs of choice to treating the disease, but they produce severe side effects and treatments fail due to drug resistance. New anti-Toxoplasma compounds are needed, and natural compounds can be a good source for obtaining them. The antiparasitic activity of 40 polar and non-polar extracts of eight antiparasitic medicinal plants used in Cote dIvoire, and selected based on ethnopharmacological survey, were evaluated in vitro against T. gondii. Among them, the hydromethanolic extract of the Elaeis guineensis leaves exhibited the best parasite growth inhibition (94% {+/-} 0.07) at 25 g/mL without being cytotoxic at the same dose. The fractionation of this extract did not allow the recovery of antitoxoplasmic activity in its individualized fractions. The 13C-NMR based dereplication of the produced fractions and the purification of one of them highlighted the presence of saccharides, terpenes, flavonoids, cardanols and aliphatic acids. The obtained clusters of 13C chemical shifts were assigned to their corresponding molecular structures with the help of open online databases, resulting in nine unambiguously identified compounds, whereas the purification of one of these fractions led to the identification of palmitic acid (10), palmitic acid methyl ester (11), 3-[12(E)-pentadecenyl]phenol (12), 3-[14(E)-heptadecenyl]phenol (13), ursolic acid (14) and stigmasta-4,24(28)-dien-3-one (15). A synergistic effect between these metabolites is thought to be responsible for the anti-Toxoplasma activity. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=112 SRC="FIGDIR/small/600452v1_ufig1.gif" ALT="Figure 1"> View larger version (57K): org.highwire.dtl.DTLVardef@17a8885org.highwire.dtl.DTLVardef@198e909org.highwire.dtl.DTLVardef@1eb643borg.highwire.dtl.DTLVardef@1018053_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGRAPHICAL ABSTRACTC_FLOATNO C_FIG HighlightsO_LIAntiparasitic activity of 40 polar and non-polar extracts of eight plants were investigated C_LIO_LIThe hydromethanolic extract of the E. guineensis leaves exhibited 94% parasite growth inhibition C_LIO_LIThe fractionation of this extract did not allow the recovery of antitoxoplasmic activity C_LIO_LINine compounds were identified by 13C-NMR based dereplication C_LIO_LISix compounds were purified from the cytotoxic fraction C_LI
- organism: plant (other)
- assay: metabolomics
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 3
- FWCI
- 2.39
- Field percentile
- top 16%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Extracts of food and medicinal plants sold in Moroccan markets induce apoptosis-like in Toxoplasma gondii tachyzoites in vitro
Ismail Elkoraichi, Nathalie Moiré, … Françoise Debierre-Grockiego·Scientific AfricanPeer-reviewed·Dec 24, 2024
- Evaluation of current and emerging anti-malarial medicines for inhibition of Toxoplasma gondii growth in vitro
J. B. Radke, J. N. Burrows, … L. D. Sibley·bioRxiv·May 8, 2018
- Screening of purine nucleoside analogues against intracellular Toxoplasma gondii.
Hamza A. A. Elati, Serge Van Calenbergh, … Harry P. de Koning·International Journal for Parasitology Drugs and Drug ResistancePeer-reviewed·Apr 10, 2026
- Legacy 4(1H)-quinolone scaffolds activity against acute and chronic Toxoplasma gondii infection
Melissa A. Sleda, Khaly Diagne, … Silvia N.J. Moreno·ACS Infectious DiseasesPeer-reviewed·May 26, 2026
- High throughput screen identifies IFN-γ-dependent inhibitors of Toxoplasma gondii growth
J. B. Radke, K. L. Carey, … L. D. D. Sibley·bioRxiv·Jun 2, 2018
- High Throughput Repurposing Screen Reveals Compounds with Activity Against Toxoplasma gondii Bradyzoites
Taher Uddin, Jing Xia, … L. David Sibley·ACS Infectious DiseasesPeer-reviewed·Feb 11, 2025